Matches in Nanopublications for { ?s ?p "[To investigate the relationship between legumain expression and ovarian cancer development, we tested legumain expression in malignant human ovarian tumors (n = 60), borderline ovarian tumors (n = 20), benign ovarian tumors (n = 20), and normal ovary samples (n = 20) using immunohistochemical assay (IHC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP854134.RAru4EsrJqwyVh98xYHO2quvVMI3YOikLgi3LHzktMsZs130_assertion description "[To investigate the relationship between legumain expression and ovarian cancer development, we tested legumain expression in malignant human ovarian tumors (n = 60), borderline ovarian tumors (n = 20), benign ovarian tumors (n = 20), and normal ovary samples (n = 20) using immunohistochemical assay (IHC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP854134.RAru4EsrJqwyVh98xYHO2quvVMI3YOikLgi3LHzktMsZs130_provenance.
- NP414129.RA5QZiruZMQfBr8YKLsQsHhTZvoVALrJA8fLVNqXG9cro130_assertion description "[To investigate the relationship between legumain expression and ovarian cancer development, we tested legumain expression in malignant human ovarian tumors (n = 60), borderline ovarian tumors (n = 20), benign ovarian tumors (n = 20), and normal ovary samples (n = 20) using immunohistochemical assay (IHC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP414129.RA5QZiruZMQfBr8YKLsQsHhTZvoVALrJA8fLVNqXG9cro130_provenance.
- NP649345.RAYtTFBPjFN-hLSz4ub6KQdXQDrkHya8O6ATftXpCDWRM130_assertion description "[To investigate the relationship between legumain expression and ovarian cancer development, we tested legumain expression in malignant human ovarian tumors (n = 60), borderline ovarian tumors (n = 20), benign ovarian tumors (n = 20), and normal ovary samples (n = 20) using immunohistochemical assay (IHC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP649345.RAYtTFBPjFN-hLSz4ub6KQdXQDrkHya8O6ATftXpCDWRM130_provenance.
- NP969809.RA3PXiDKol_wQSqJit3EN8GQ24MzgjU2jZY-JiBiy-DBE130_assertion description "[To investigate the relationship between legumain expression and ovarian cancer development, we tested legumain expression in malignant human ovarian tumors (n = 60), borderline ovarian tumors (n = 20), benign ovarian tumors (n = 20), and normal ovary samples (n = 20) using immunohistochemical assay (IHC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP969809.RA3PXiDKol_wQSqJit3EN8GQ24MzgjU2jZY-JiBiy-DBE130_provenance.
- NP969810.RA-vNBBrSSHH96atgV-iS2Q3oRWC3OeUjaG7nmQ_cOMRE130_assertion description "[To investigate the relationship between legumain expression and ovarian cancer development, we tested legumain expression in malignant human ovarian tumors (n = 60), borderline ovarian tumors (n = 20), benign ovarian tumors (n = 20), and normal ovary samples (n = 20) using immunohistochemical assay (IHC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP969810.RA-vNBBrSSHH96atgV-iS2Q3oRWC3OeUjaG7nmQ_cOMRE130_provenance.
- NP649318.RAHDgmT3K3BnLtLrjA2WyL9LJNdM_70_DPJKLBiLLerHw130_assertion description "[To investigate the relationship between legumain expression and ovarian cancer development, we tested legumain expression in malignant human ovarian tumors (n = 60), borderline ovarian tumors (n = 20), benign ovarian tumors (n = 20), and normal ovary samples (n = 20) using immunohistochemical assay (IHC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP649318.RAHDgmT3K3BnLtLrjA2WyL9LJNdM_70_DPJKLBiLLerHw130_provenance.